Jason Carroll
Amministratore Delegato presso TRYPTAMINE THERAPEUTICS LIMITED
Patrimonio netto: 15 $ in data 30/04/2024
Profilo
Jason Carroll currently works at Tryp Therapeutics, Inc., as Chief Executive Officer from 2023.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
TRYP THERAPEUTICS, INC.
0.00% | 20/11/2023 | 325 ( 0.00% ) | 15 $ | 30/04/2024 |
Posizioni attive di Jason Carroll
| Società | Posizione | Inizio |
|---|---|---|
| TRYPTAMINE THERAPEUTICS LIMITED | Amministratore Delegato | 01/10/2023 |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 1 |
|---|---|
Tryp Therapeutics, Inc.
 Tryp Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Tryp Therapeutics, Inc. is a pharmaceutical company, which engages in identifying and developing clinical-stage compounds for orphan diseases and other diseases with high unmet medical needs. The company was founded on September 24, 2019 and is headquartered in Kelowna, Canada. | Health Technology |
- Borsa valori
- Insiders
- Jason Carroll
